APA (7th ed.) Citation

MHE, K., BN, A., RM, Z., R, B., RM, Y., MA, A., . . . HM, E. (2026). Intranasal co-delivery of riluzole and berberine via chitosan-coated PLGA nanoparticles for synergistic neuroprotection in Alzheimer's disease: Formulation, characterization, and pharmacokinetics analysis. Naunyn-Schmiedeberg's archives of pharmacology, 399(9), 14123. https://doi.org/10.1007/s00210-026-05182-3

Chicago Style (17th ed.) Citation

MHE, Komy, Aldosari BN, Zaki RM, Bafail R, Yusif RM, Abdelgawad MA, Elmowafy M, Abuhelwa AY, and Eid HM. "Intranasal Co-delivery of Riluzole and Berberine via Chitosan-coated PLGA Nanoparticles for Synergistic Neuroprotection in Alzheimer's Disease: Formulation, Characterization, and Pharmacokinetics Analysis." Naunyn-Schmiedeberg's Archives of Pharmacology 399, no. 9 (2026): 14123. https://doi.org/10.1007/s00210-026-05182-3.

MLA (9th ed.) Citation

MHE, Komy, et al. "Intranasal Co-delivery of Riluzole and Berberine via Chitosan-coated PLGA Nanoparticles for Synergistic Neuroprotection in Alzheimer's Disease: Formulation, Characterization, and Pharmacokinetics Analysis." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 399, no. 9, 2026, p. 14123, https://doi.org/10.1007/s00210-026-05182-3.